DealZone

Deals wrap: Dealing with regulation

October 6, 2010

Traders work on the floor of the New York Stock Exchange near the Goldman Sachs stall July 16, 2010. REUTERS/Brendan McDermidBanks are self-regulating in advance of new financial reforms. Are recent moves by Goldman Sachs and JPMorgan “smoke and mirrors” or a way to subtly shift the form of impending regulation? *View analysis *View Q&A on Wall Street reform*Full coverage of regulatory news

“Unlocking the potential of Genzyme’s experimental multiple sclerosis drug Campath could be key to prying a higher price for the U.S. biotech from Sanofi-Aventis,” writes Lewis Krauskopf and Ben Hirschler. *View analysis *View WSJ blog

General Electric is building up its industrial business with a $3 billion bid for Dresser Inc. The deal announcement came the same day as oilfield services company Wellstream rejected GE’s takeover approach. *View article

Children’s apparel retailer Gymboree is exploring a sale of the company, sources say.  Lisa Lee at Dow Jones Investment Banker takes a look at why the company is so attractive to private equity firms. *View article

Post Your Comment

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/